
Investors must take note of Spyre Therapeutics Inc’s (SYRE) performance last week, which was 1.40%.
On Monday, Spyre Therapeutics Inc (NASDAQ: SYRE) was -4.99% drop from the session before settling in for the closing price of $16.02. A 52-week range